Is aspirin safe for patients with heart failure?
作者信息
Cleland J G, Bulpitt C J, Falk R H, Findlay I N, Oakley C M, Murray G, Poole-Wilson P A, Prentice C R, Sutton G C
机构信息
Western Infirmary, Glasgow.
出版信息
Br Heart J. 1995 Sep;74(3):215-9. doi: 10.1136/hrt.74.3.215.
Abstract
摘要
相似文献
1
Is aspirin safe for patients with heart failure?阿司匹林对心力衰竭患者是否安全？
Br Heart J. 1995 Sep;74(3):215-9. doi: 10.1136/hrt.74.3.215.
2
Antithrombotic therapy in heart failure.心力衰竭中的抗血栓治疗。
Expert Rev Cardiovasc Ther. 2006 May;4(3):277-8. doi: 10.1586/14779072.4.3.277.
3
Is the lower mortality in patients treated with aspirin and angiotensin-converting enzyme inhibitors due to decreased norepinephrine release?
J Am Coll Cardiol. 2000 Mar 1;35(3):817-9. doi: 10.1016/s0735-1097(99)00618-x.
4
5
Use of aspirin in conjunction with angiotensin-converting enzyme inhibitors does not worsen long-term survival in heart failure.阿司匹林与血管紧张素转换酶抑制剂联合使用不会降低心力衰竭患者的长期生存率。
Int J Cardiol. 2003 Apr;88(2-3):207-14. doi: 10.1016/s0167-5273(02)00401-1.
6
Heart failure: a diagnostic and therapeutic dilemma in elderly patients.心力衰竭：老年患者的诊断与治疗困境
Age Ageing. 1999 May;28(3):328-9. doi: 10.1093/ageing/28.3.328.
7
Aspirin and heart failure: square evidence meets a round patient.
Congest Heart Fail. 2003 Jul-Aug;9(4):203-5. doi: 10.1111/j.1527-5299.2003.01716.x.
8
Aspirin and mortality in patients treated with angiotensin-converting enzyme inhibitors: a cohort study of 11,575 patients with coronary artery disease.血管紧张素转换酶抑制剂治疗患者中阿司匹林与死亡率：一项针对11575例冠心病患者的队列研究
J Am Coll Cardiol. 1999 Jun;33(7):1920-5. doi: 10.1016/s0735-1097(99)00129-1.
9
[Which interactions are there for equal doses of acetylsalicylic acid and ACE inhibitors?].
Dtsch Med Wochenschr. 2003 Feb 21;128(8):398. doi: 10.1055/s-2003-37373.
10
Controversies in heart failure. Are beneficial effects of angiotensin-converting enzyme inhibitors attenuated by aspirin in patients with heart failure?心力衰竭中的争议。血管紧张素转换酶抑制剂对心力衰竭患者的有益作用会被阿司匹林减弱吗？
Cardiol Clin. 2001 Nov;19(4):597-603. doi: 10.1016/s0733-8651(05)70246-0.
引用本文的文献
1
Korean Society of Heart Failure Guidelines for the Management of Heart Failure: Management of the Underlying Etiologies and Comorbidities of Heart Failure.韩国心力衰竭管理指南：心力衰竭潜在病因及合并症的管理
Int J Heart Fail. 2023 Jul 13;5(3):127-145. doi: 10.36628/ijhf.2023.0016. eCollection 2023 Jul.
2
Korean Society of Heart Failure Guidelines for the Management of Heart Failure: Management of the Underlying Etiologies and Comorbidities of Heart Failure.韩国心力衰竭管理指南：心力衰竭潜在病因及合并症的管理
Korean Circ J. 2023 Jul;53(7):425-451. doi: 10.4070/kcj.2023.0114.
3
Fighting against sudden death: a single or multidisciplinary approach.对抗猝死：单一方法还是多学科方法。
J Interv Card Electrophysiol. 2006 Dec;17(3):205-10. doi: 10.1007/s10840-006-9077-6. Epub 2007 Apr 6.
4
Does aspirin attenuate the beneficial effect of ACE inhibitors in elderly people with heart failure?阿司匹林会减弱血管紧张素转换酶抑制剂对老年心力衰竭患者的有益作用吗？
Drugs Aging. 2005;22(7):605-14. doi: 10.2165/00002512-200522070-00006.
5
Blood coagulation in patients with chronic heart failure: evidence for hypercoagulable state and potential for pharmacological intervention.慢性心力衰竭患者的血液凝固：高凝状态的证据及药物干预的潜力
Drugs. 2003;63(6):565-76. doi: 10.2165/00003495-200363060-00004.
6
Effect of aspirin on vasodilation to bradykinin and substance P in patients with heart failure treated with ACE inhibitor.阿司匹林对接受血管紧张素转换酶抑制剂治疗的心力衰竭患者缓激肽和P物质血管舒张作用的影响。
Br J Clin Pharmacol. 2002 Jan;53(1):37-42. doi: 10.1046/j.0306-5251.2001.01524.x.
7
Chronic aspirin is effective--if data are massaged sufficiently.长期服用阿司匹林是有效的——只要对数据进行充分处理。
BMJ. 2002 Feb 2;324(7332):295.
8
Preventing atherosclerotic events with aspirin.使用阿司匹林预防动脉粥样硬化事件。
BMJ. 2002 Jan 12;324(7329):103-5. doi: 10.1136/bmj.324.7329.103.
9
Aspirin and ACE-inhibitors: for wedding or funeral?阿司匹林和血管紧张素转换酶抑制剂：是用于喜事还是丧事？
J Thromb Thrombolysis. 2001 Apr;11(2):163-9. doi: 10.1023/a:1011232918173.
10
Interaction between aspirin and ACE inhibitors in patients with heart failure.心力衰竭患者中阿司匹林与血管紧张素转换酶抑制剂的相互作用。
Drug Saf. 2001;24(3):167-82. doi: 10.2165/00002018-200124030-00002.
本文引用的文献
1
Platelet function, thrombin and fibrinolytic activity in patients with heart failure.
Eur Heart J. 1993 Feb;14(2):205-12. doi: 10.1093/eurheartj/14.2.205.
2
Fat-suppressed breath-hold magnetic resonance coronary angiography.
Circulation. 1993 Jan;87(1):94-104. doi: 10.1161/01.cir.87.1.94.
3
Low incidence of stroke in ambulatory patients with heart failure: a prospective study.门诊心力衰竭患者中风发生率低：一项前瞻性研究。
Am Heart J. 1993 Jul;126(1):141-6. doi: 10.1016/s0002-8703(07)80021-4.
4
The clinical course of heart failure and its modification by ACE inhibitors: insights from recent clinical trials.心力衰竭的临床病程及其由血管紧张素转换酶抑制剂带来的改善：近期临床试验的见解
Eur Heart J. 1994 Jan;15(1):125-30. doi: 10.1093/oxfordjournals.eurheartj.a060364.
5
Relationship between hemostatic abnormalities and neuroendocrine activity in heart failure.心力衰竭中止血异常与神经内分泌活动的关系。
Am Heart J. 1994 Mar;127(3):607-12. doi: 10.1016/0002-8703(94)90670-x.
6
7
Management of heart failure. IV. Anticoagulation for patients with heart failure due to left ventricular systolic dysfunction.
JAMA. 1994;272(20):1614-8. doi: 10.1001/jama.272.20.1614.
8
ACE inhibitors for heart failure: a question of dose.用于治疗心力衰竭的血管紧张素转换酶抑制剂：剂量问题。
Br Heart J. 1994 Sep;72(3 Suppl):S106-10. doi: 10.1136/hrt.72.3_suppl.s106.
9
Enhanced basal nitric oxide production in heart failure: another failed counter-regulatory vasodilator mechanism?
Lancet. 1994 Aug 6;344(8919):371-3. doi: 10.1016/s0140-6736(94)91402-8.
10
Peripheral haemodynamic effects of inhibition of prostaglandin synthesis in congestive heart failure and interactions with captopril.充血性心力衰竭中前列腺素合成抑制的外周血流动力学效应及其与卡托普利的相互作用
Br Heart J. 1995 May;73(5):434-41. doi: 10.1136/hrt.73.5.434.
Zotero 插件